People | July 27, 2025
Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
The inspection was conducted from July 22-25, 2025
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
The company received one observation in the Form-483
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
The INSPIRE-1 and INSPIRE-2 trials are Phase 3 studies assessing the efficacy and safety of tildrakizumab 100 mg (ILUMYA) in adults with active psoriatic arthritis (PsA)
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
Subscribe To Our Newsletter & Stay Updated
